Skip to main content

Advertisement

SpringerLink
Log in

Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

To assess Fear of Cancer Recurrence (FCR)—its prevalence, trajectory, and relationship to several demographic and clinical characteristics, and quality of life—in a sample of peritoneal malignancy survivors, up to 5 years post-surgery.

Methods

The Fear of Cancer Recurrence Inventory—Short Form (FCRI-SF) and 36-Item Short-Form Health Survey (SF-36) were used to collect cross-sectional data from peritoneal malignancy survivors to assess their Fear of Cancer Recurrence and quality of life respectively as well as other demographic and clinical data.

Results

The results show that more than two-thirds of the participants (N = 301) experience severe/clinical FCR. FCR is relatively stable over time. Younger patients who are struggling with anxiety or depression or receiving professional mental health support at the time of the surgery are at a higher risk of FCR. FCR is associated with a worse quality of life.

Conclusions

Peritoneal malignancy survivors are at a high risk of FCR, and it compromises their psychological, mental, and social well-being (quality of life).

Implications for cancer survivors.

Raise awareness about the high risk of FCR in this population and the demographic and clinical factors that are associated with it. Encourage peritoneal malignancy services and health professionals to address FCR in this population by normalizing it and providing support for those struggling with it.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request. Only anonymized data can be provided.

References

  1. Butow P, Sharpe L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park). 2018;32(1):32–8.

    PubMed  Google Scholar 

  2. Tauber NM, O’Toole MS, Dinkel A, Galica J, Humphris G, Lebel S, ... & Sharpe L. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019; 37 31:2899

  3. Almeida SN, Elliott R, Silva ER, Sales CM. Fear of cancer recurrence: a qualitative systematic review and meta-synthesis of patients’ experiences. Clin Psychol Rev. 2019;68:13–24.

    Article  PubMed  Google Scholar 

  4. Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith AB, ... & Butow P. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv. 2016 10 4:663-673

  5. Butow PN, Turner J, Gilchrist J, Sharpe L, Smith AB, Fardell JE, ... & Thewes B. Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol. 2017; 35 36:4066-4077

  6. Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9(3):481–91. https://doi.org/10.1007/s11764-015-0424-4.

    Article  PubMed  Google Scholar 

  7. Luigjes‐Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WW, Lebel S, ... & van der Lee ML. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis. Psycho‐Oncology. 2022

  8. Custers JA, Gielissen MF, Janssen SH, de Wilt JH, Prins JB. Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. 2016;24(2):555–62.

    Article  PubMed  Google Scholar 

  9. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.

    Article  PubMed  Google Scholar 

  10. Thewes B, Butow P, Bell ML, Beith J, Stuart-Harris R, Grossi M, ... & Dalley D. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Supp Care Cancer. 2012; 20 11:2651-2659

  11. Swain D, Mason G, Yates A, Burke S, Cecil T, Mohamed F, Dayal S, Tzivanakis A, Moran B. Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract origin. Eur J Clin Nutr. 2020;75(5):856–8. https://doi.org/10.1038/s41430-020-00810-4.

    Article  PubMed  Google Scholar 

  12. Ahmadi N, Kostadinov D, Sakata S, Ball W R, Gandhi J, Carr NJ, ... & Moran BJ. Managing recurrent pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: a dilemma for patients and surgeons. Annals of Surgical Oncology. 2021; 1–12

  13. Consonni D, Calvi C, De Matteis S, Mirabelli D, Landi MT, Caporaso NE, ... & Mensi C. Peritoneal mesothelioma and asbestos exposure: a population-based case–control study in Lombardy, Italy. Occup Environ Med. 2019; 76 8:545–53.

  14. Huang Y, Alzahrani NA, Chua TC, Morris DL. Histological subtype remains a significant prognostic factor for survival outcomes in patients with appendiceal mucinous neoplasm with peritoneal dissemination. Dis Colon Rectum. 2017;60(4):360–7.

    Article  PubMed  Google Scholar 

  15. März L, Piso P. Treatment of peritoneal metastases from colorectal cancer. Gastroenterol Report. 2015;3(4):298–302.

    Google Scholar 

  16. Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal peritoneal metastases: optimal management review. World J Gastroenterol. 2019;25(27):3484.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Witham G, Willard C, Ryan-Woolly B, O’Dwyer ST. A study to explore the patient’s experience of peritoneal surface malignancies: Pseudomyxoma peritonei. Eur J Oncol Nurs. 2008;12(2):112–9.

    Article  CAS  PubMed  Google Scholar 

  18. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727–31.

    Article  CAS  PubMed  Google Scholar 

  19. Chiu CC, Lee PH, Chang CS, Rau KM, Hung CM. Correspondence to ‘Treatment of peritoneal disease in Stomach Cancer with cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy: PERISCOPE I initial results.’ British J Surg. 2021;108(2):e93. https://doi.org/10.1093/bjs/znaa126.

    Article  Google Scholar 

  20. Zhu Y, Hanna N, CherifBoutros H Jr. Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases. J Gastrointest Oncol. 2013;4(1):62.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Tentes AA, Pallas N, Korakianitis O, Mavroudis C, Spiridonidou A, Zorbas G, Popidis S, Papadoniou N, Darladima V, Smyrnis A, Siopis C. The cost of cytoreductive surgery and perioperative intraperitoneal chemotherapy in the treatment of peritoneal malignancy in one Greek institute. J BUON. 2012;17:776–80.

    CAS  PubMed  Google Scholar 

  22. Govaerts K, Chandrakumaran K, Carr NJ, Cecil TD, Dayal S, Mohamed F, ... & Moran BJ Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei. European J Surg Oncol. 2018; 44 9:1371-1377

  23. Butow PN, Fardell JE, & Smith A. (2015). Fear of cancer recurrence: an overview and Australian perspective. In Cancer Forum. 39 2:95. The Cancer Council Australia

  24. Peng L, Huang W, Zhang W, Xu Y, Lu F, Zhong L, ... & Li M. Psychometric properties of the short form of the fear of cancer recurrence inventory (FCRI) in Chinese breast cancer survivors. Front Psychiatry. . 2019; 10:537

  25. Smith AB, Costa D, Galica J, Lebel S, Tauber N, van Helmondt SJ, Zachariae R. Spotlight on the fear of cancer recurrence inventory (FCRI). Psychol Res Behav Manag. 2020;13:1257.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ftanou M. Feasibility and acceptability of fear-less: a stepped-care program to manage fear of cancer recurrence in people with metastatic melanoma. J Clin Med. 2020;9(9):2969.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Hoffner M, Bagheri S, Hansson E, Manjer J, Troëng T, Brorson H. SF-36 shows increased quality of life following complete reduction of postmastectomy lymphedema with liposuction. Lymphat Res Biol. 2017;15(1):87–98.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Silva GE, Goodwin JL, Vana KD, Quan SF. Obstructive sleep apnea and quality of life: comparison of the SAQLI, FOSQ, and SF-36 questionnaires. Southwest Journal of Pulmonary & Critical Care. 2016;13(3):137.

    Article  Google Scholar 

  29. IBM Corp. Released 2020. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp

  30. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Supportive care in cancer. 2009 Mar;17(3):241–51.

    Article  PubMed  Google Scholar 

  31. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  32. Lebel S, Beattie S, Arès I, Bielajew C. Young and worried: age and fear of recurrence in breast cancer survivors. Health Psychol. 2013;32(6):695.

    Article  PubMed  Google Scholar 

  33. Hanprasertpong J, Geater A, Jiamset I, Padungkul L, Hirunkajonpan P, & Songhong N. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecologic Oncol. 2017; 28 6

Download references

Acknowledgements

We thank our colleagues at the Peritoneal Malignancy Institute for their support in conducting this study. We are grateful for our patients who took the time to participate in this study.

Funding

This work was supported by the Peritoneal Malignancy Institute charitable fund.

Author information

Authors and Affiliations

  1. Peritoneal Malignancy Institute, Hampshire Hospitals NHS Foundation Trust, Ground Floor, The Ark, Dinwoodie Drive, Basingstoke, RG24 9NN, UK

    Rayan Taher, Norman John Carr, Nancy Vanderpuye & Sophia Stanford

Authors
  1. Rayan Taher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman John Carr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nancy Vanderpuye
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sophia Stanford
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by RT. The first draft of the manuscript was written by RT, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Rayan Taher.

Ethics declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from the HRA and Health and Care Research Wales (HCRW) (IRAS ID: 295431).

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taher, R., Carr, N.J., Vanderpuye, N. et al. Fear of Cancer Recurrence in peritoneal malignancy patients following treatment: a cross-sectional study. J Cancer Surviv 17, 300–308 (2023). https://doi.org/10.1007/s11764-022-01238-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-022-01238-4

Keywords

Search

Navigation